Jaguar Health, Inc.
JAGX
$1.76
-$0.03-1.68%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 15.95% | 13.93% | 19.75% | -2.25% | -7.89% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 15.95% | 13.93% | 19.75% | -2.25% | -7.89% |
| Cost of Revenue | 3.98% | -3.86% | -4.03% | 13.01% | 5.86% |
| Gross Profit | 18.99% | 18.63% | 26.02% | -5.42% | -10.83% |
| SG&A Expenses | 22.46% | 15.40% | 4.23% | 1.48% | -8.09% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.43% | 2.73% | -2.66% | -7.78% | -8.00% |
| Operating Income | -4.66% | 0.78% | 9.11% | 9.57% | 8.04% |
| Income Before Tax | -14.37% | -4.13% | 6.32% | 6.12% | 20.47% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -14.37% | -4.13% | 6.32% | 6.12% | 20.47% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 41.07% | 36.68% | 26.29% | -47.53% | -49.54% |
| Net Income | -13.96% | -3.67% | 6.80% | 4.96% | 19.77% |
| EBIT | -4.66% | 0.78% | 9.11% | 9.57% | 8.04% |
| EBITDA | -5.12% | 0.40% | 9.33% | 9.91% | 8.39% |
| EPS Basic | 92.07% | 96.62% | 92.71% | 75.10% | 9.67% |
| Normalized Basic EPS | 94.01% | 97.04% | 93.05% | 78.70% | -16.19% |
| EPS Diluted | 92.07% | 96.62% | 92.71% | 75.10% | 9.67% |
| Normalized Diluted EPS | 94.01% | 97.04% | 93.05% | 78.70% | -16.19% |
| Average Basic Shares Outstanding | -33.09% | 2,977.82% | 7,683.51% | 15,862.11% | 31,470.34% |
| Average Diluted Shares Outstanding | -33.09% | 2,977.82% | 7,683.51% | 15,862.11% | 31,470.34% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |